The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 91 for:    minority chicago

Deliberate Ultraviolet Light Exposure to Get a Tan by Young Adult Sexual Minority Males

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04404907
Recruitment Status : Completed
First Posted : May 28, 2020
Results First Posted : December 10, 2020
Last Update Posted : January 5, 2021
Sponsor:
Information provided by (Responsible Party):
June Robinson, Northwestern University

Brief Summary:
The purpose of this study is to: a) identify enablers and barriers to deliberate ultraviolet light exposure by young sexual minority men (SMM), and b) quantify the extent of their deliberate ultraviolet light exposure.

Condition or disease Intervention/treatment
Sun Sensitivity Other: no intervention

Detailed Description:

Aim 1: To develop survey items to assess tanning attitudes and behaviors Nine survey items used by the PI in previous deliberate tanning research were adapted with the expert consensus of members of Northwestern's Institute for Sexual and Gender Minority Health and Wellbeing. Discussions with the PI, research personnel and members of the institute developed the hypothesis that in addition to the previously reported appearance motivations young SMM may be engaging in tanning (indoors or outdoors) as a social activity. A tenth survey item was developed to assess deliberate tanning as a social activity.

Aim 2: Analyze the tanning attitudes and behavior data acquired in an online survey of young adult sexual minority males, who regularly participate in the RADAR study.

RADAR is a longitudinal study with cohorts from the greater Chicago region recruited between 2008 and 2015. The 10 survey items about tanning attitudes and behaviors were added to the online survey that examines SMMs' behavior in the prior 6 months. This is a secondary analysis of registry data acquired by the RADAR study.

Layout table for study information
Study Type : Observational
Actual Enrollment : 537 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: Analysis of Tanning Attitudes and Behaviors by Young Adult Sexual Minority Males in the Greater Chicago Area
Actual Study Start Date : July 15, 2019
Actual Primary Completion Date : September 5, 2020
Actual Study Completion Date : September 5, 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Males who never deliberately tan
Males responded to an anonymous online survey that they never deliberately tan
Other: no intervention
This is a secondary analysis of registry data.

Males who ever deliberately tan
Males responded to an anonymous online survey that they had ever deliberately tan
Other: no intervention
This is a secondary analysis of registry data.




Primary Outcome Measures :
  1. Outdoor Tanning Motives [ Time Frame: 14 days ]
    The 95 participants who self-reported deliberate tanning responded to 7 online survey items reported in the analysis population description.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 39 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Participants self-identify as sexual minority males
Sampling Method:   Probability Sample
Study Population
RADAR is a longitudinal study with cohorts from the greater Chicago region recruited between 2008 and 2015. Participants respond to online surveys every 6 months.
Criteria

Inclusion Criteria:

  • Young adult SMM (age 18-39)
  • Able to read English
  • Have internet access
  • Willing to complete the online survey

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04404907


Locations
Layout table for location information
United States, Illinois
Northwestern University Feinberg School of Medicine Department of Dermatology
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Investigators
Layout table for investigator information
Principal Investigator: June K Robinson, MD Northwestern University
  Study Documents (Full-Text)

Documents provided by June Robinson, Northwestern University:
Study Data/Documents: Clinical Study Report  This link exits the ClinicalTrials.gov site
Mustanski, Brian. Multilevel Influences on HIV and Substance Use in a YMSM Cohort (RADAR) - Visit #1, Chicago Metropolitan Area, 2015-2018. Inter-university Consortium for Political and Social Research [distributor], 2020-03-19.

Publications of Results:
Layout table for additonal information
Responsible Party: June Robinson, Research Professor of Dermatology, Northwestern University
ClinicalTrials.gov Identifier: NCT04404907    
Other Study ID Numbers: STU00206314
First Posted: May 28, 2020    Key Record Dates
Results First Posted: December 10, 2020
Last Update Posted: January 5, 2021
Last Verified: December 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Since all data is deidentified, the results cannot be shared individually; however, the results may be provided to the entire cohort in a newsletter.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypersensitivity
Immune System Diseases